We are live on ! Find out more
ALHC icon

Alignment Healthcare

150 hedge funds and large institutions have $1.86B invested in Alignment Healthcare in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 52 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,160% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 5

148% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 21

63% more funds holding

Funds holding: 92150 (+58)

4% more capital invested

Capital invested by funds: $1.78B → $1.86B (+$79M)

0.62% more ownership

Funds ownership: 83.28%83.9% (+0.62%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
150
Holders Change
+58
Holders Change %
+63.04%
% of All Funds
2.58%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
52
Reduced
21
Closed
5
Calls
$791K
Puts
Net Calls
+$791K
Net Calls Change
+$503K
Name Holding Trade Value Shares
Change
Change in
Stake
GA
1
General Atlantic
New York
$722M -$132M -9,075,994 -13%
WP
2
Warburg Pincus
New York
$212M -$70.7M -4,846,006 -21%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$199M +$2.41K +165 +0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$96.1M +$23.7M +1,626,831 +25%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$87.2M +$107M +7,361,208 New
BlackRock
6
BlackRock
New York
$67.5M +$14.9M +1,020,637 +22%
Brown Advisory
7
Brown Advisory
Maryland
$44.5M +$571K +39,154 +1%
Capital World Investors
8
Capital World Investors
California
$41.4M
Marshall Wace
9
Marshall Wace
United Kingdom
$34.1M +$42.1M +2,882,359 New
Goldman Sachs
10
Goldman Sachs
New York
$25.7M +$15.3M +1,048,996 +93%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$25.5M -$97.1M -6,651,242 -76%
State Street
12
State Street
Massachusetts
$20M +$4.75M +325,532 +24%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$18.2M +$22.4M +1,537,432 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$18.2M +$6.9M +472,786 +44%
Amundi
15
Amundi
France
$14.8M -$1.07M -73,433 -6%
Citadel Advisors
16
Citadel Advisors
Florida
$14.5M +$10.6M +727,930 +146%
Morgan Stanley
17
Morgan Stanley
New York
$14.4M +$6.52M +447,120 +58%
DCP
18
Durable Capital Partners
Maryland
$12M -$81.8M -5,605,939 -85%
Northern Trust
19
Northern Trust
Illinois
$9.15M +$1.36M +93,513 +14%
Norges Bank
20
Norges Bank
Norway
$8.77M +$7.72M +529,047 +250%
CSS
21
Cubist Systematic Strategies
Connecticut
$8.18M +$9.61M +658,671 +2,022%
N
22
Nuveen
North Carolina
$7.98M +$1.2M +82,242 +14%
Charles Schwab
23
Charles Schwab
California
$7.79M +$4.87M +334,055 +103%
EAM
24
Eagle Asset Management
Florida
$7.72M -$1.47M -100,679 -13%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$7.41M +$9.14M +625,981 New

ALHC Hedge Fund Activity: Q3 2022 in Review

150 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Alignment Healthcare (ALHC) for Q3 2022, worth a combined $1.86B — up 4.4% from $1.78B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new ALHC positions and 5 closed out — a net gain of 58 holders — while 52 added to existing stakes and 21 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $42.1M. The largest seller was General Atlantic, cutting an estimated $132M.

  • 150 institutional investors held Alignment Healthcare (ALHC) as of Q3 2022, up from 92 in Q2 2022.
  • Funds reported $1.86B of Alignment Healthcare stock for Q3 2022, up 4.4% quarter-over-quarter.
  • 63 funds opened new Alignment Healthcare positions in Q3 2022 and 5 closed out, a net change of +58 holders.
  • The largest Alignment Healthcare buyer in Q3 2022 was Marshall Wace, an estimated $42.1M added.
  • The largest Alignment Healthcare seller in Q3 2022 was General Atlantic, an estimated $132M sold.

Based on aggregated 13F filings for Q3 2022.